Statin-induced dermatomyositis for the practicing dermatologist: a review of the literature. Review uri icon

Overview

abstract

  • Statins cause a spectrum of muscle-related adverse events, including autoimmune myopathies such as dermatomyositis (DM). This review aims to describe the events of statin-induced DM and amyopathic dermatomyositis (ADM) to increase awareness for practicing dermatologists about harmful interactions with the most commonly prescribed lipid-lowering medication. PubMed was searched for relevant literature related to statin-induced DM and ADM. Numerous cases of statin-induced DM have been reported in individuals with no history of DM or other autoimmune conditions. Statins also cause ADM, although this is a rare association. Because of the widespread use of statins worldwide for atherosclerotic disease prevention, it may be of benefit to practicing dermatologists and all clinicians to assess for a history of DM when prescribing statins and inquire if patients with a DM-like presentation are taking or have taken a statin medication.

publication date

  • December 15, 2019

Research

keywords

  • Dermatomyositis
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors

Identity

Scopus Document Identifier

  • 85077088971

Digital Object Identifier (DOI)

  • 10.1111/ijd.14751

PubMed ID

  • 31840246

Additional Document Info

volume

  • 59

issue

  • 3